Mizuho has increased its price target for BridgeBio Pharma (BBIO) from $91 to $106. The move reflects the firm's updated outlook for the biopharmaceutical company.
- Yahoo is part of the settings'
- and apps
- andCookie Policy
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.
Share this article